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ABSTRACT
Objectives: In the salivary glands of patients with
primary Sjo¨gren Syndrome (pSjS) an accumulation of
dendritic cells (DCs) is seen, which is thought to play a
role in stimulating local inflammation. Aberrancies in
subsets of monocytes, generally considered the blood
precursors for DCs, may play a role in this accumulation of
DCs. This study is aimed at determining the level of
mature CD14lowCD16+ monocytes in pSjS and their
contribution to the accumulation of DCs in pSjS.
Methods: Levels of mature and immature monocytes in
patients with pSjS (n = 19) and controls (n = 15) were
analysed by flow cytometry. The reverse transmigration
system was used for generation of DCs generated from
monocyte subsets. The phenotype of DCs in pSjS salivary
glands was analysed using immunohistochemistry. In vivo
tracking of monocyte subsets was performed in a mouse
model.
Results: Increased levels of mature CD14lowCD16+
monocytes were found in patients with pSjS (mean (SD)
14.5 (5.5)% vs 11.4 (3.4)%). These cells showed normal
expression of chemokine receptor and adhesion mole-
cules. Mature monocytes partly developed into DC-
lysosome-associated membrane glycoprotein (LAMP)+
(19.6 (7.5)%) and CD83+ (16 (9)%) DCs, markers also
expressed by DCs in pSjS salivary glands. Monocyte
tracking in the non-obese diabetic (NOD) mouse showed
that the homologue population of mature mouse
monocytes migrated to the salivary glands, and prefer-
entially developed into CD11c+ DCs in vivo.
Conclusions: Mature monocytes are increased in pSjS
and patient and mouse data support a model where this
mature monocyte subset migrates to the salivary glands
and develops into DCs.
Primary Sjo¨gren syndrome (pSjS) is an autoim-
mune disorder characterised by focal lymphocytic
infiltrates in the salivary and lachrymal glands.1
Although the pathogenesis remains to be fully
elucidated, several findings indicate involvement of
the innate immune system. These include
increased expression of Toll-like receptors and
upregulation of the type I interferon (IFN)
system.2–5 Furthermore, in labial biopsies, increased
numbers of dendritic cells (DCs) were observed.6
Interestingly, in the non-obese diabetic (NOD)
animal model for pSjS, a strong accumulation of
DCs was observed prior to the appearance of
infiltrates.7 DCs are potent antigen-presenting cells
and play a key role in the development of immune
responses by stimulating T cells and boosting B cell
responses.8–10 Therefore, the increased presence of
DCs is likely to play a role in the initiation and
perpetuation of local immunity.
The increased presence of DCs in the pSjS
salivary gland may involve aberrancies in the
precursor population of blood monocytes.
Interestingly, monocyte alterations have been
described in other autoimmune conditions such
as rheumatoid arthritis (RA) and diabetes, and
include increased expression of Fc receptors,
increased adhesion to extracellular matrix and
shifts in monocyte subsets.11–13 In humans, mono-
cytes can be separated in two populations, based
on expression of CD14 and CD16. The majority of
monocytes are CD14+CD16–, but approximately
10% are CD14lowCD16+ and this is considered to be
a relatively mature population.14 15 CD16+ mature
monocytes are further characterised by high levels
of CX3CR1 and low levels of chemokine (C–C
motif) receptor 2 (CCR2) and CD62L.16 CD16–
immature monocytes have been hypothesised to
convert into mature CD16+,17 which in turn
develop into DCs. Indeed, CD16+ monocytes have
been shown to preferentially develop into tissue-
trafficking DCs in an in vitro model.17 In the mouse
system, the populations of Ly-6Chigh and Ly-6Clow
monocytes are considered to be homologous to the
human CD16– and CD16+ subsets.15 Supporting
the idea of a kinetic relationship between the two
subsets, in mice it has been shown that in vivo, Ly-
6Chigh monocytes develop into Ly-6Clow mono-
cytes.18
Previously, increased levels of mature monocytes
were described in RA and infectious diseases such
as HIV and sepsis.13 19–21 In human pSjS, no data
has been reported on the levels of mature mono-
cytes. However, in the NOD mouse,22 the mature
monocyte subset is increased significantly.23 The
purpose of this study was to determine if the
mature monocyte subset is expanded in pSjS and if
DCs derived from this subset contribute to the
accumulation of activated DCs observed in the
salivary glands of these patients.
MATERIALS AND METHODS
Patients and controls
Heparinised blood samples were obtained from 19
female patients with pSjS fulfilling the American–
European consensus criteria24 (mean (SD) age 52.5
(16.8) years, mean disease duration 8.2 (9.1) years)
at Erasmus MC, Rotterdam, The Netherlands (see
Supplementary material). Patients treated with
corticosteroids were excluded. Disease duration
was determined as time from initial diagnosis to
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time of inclusion. Control samples were obtained from 15
female volunteers (mean age 46.2 (6.0) years) not suffering from
autoimmune diseases or taking immunosuppressive medication.
Labial biopsies of six subjects were obtained during diagnostic
biopsy procedures at the Erasmus MC. Two patients were
diagnosed as pSjS according to the criteria mentioned above,
and four did not meet any of the objective criteria for pSjS and
were considered controls. Parotid biopsies of two patients
fulfilling the criteria for pSjS were obtained at the University
Medical Center Groningen, Groningen, The Netherlands in the
course of another study.25 All subjects gave informed consent
and experimental procedures were approved by the Medical
Ethical Committees of Erasmus MC and University Medical
Center Groningen.
Mice
NOD/LTj mice were bred and housed in our own facility under
specified pathogen-free conditions. All experimental procedures
were approved by the Erasmus University Animal Ethical
Committee.
Cell isolations
Peripheral blood mononuclear cells (PBMCs) were isolated from
peripheral blood using a Ficoll gradient (Amersham, Little
Chalfont, UK). When appropiate, CD16+ and CD16– popula-
tions were separated using CD16-microbeads and AutoMACS
separation (Miltenyi, Bergisch Gladbach, Germany).
Flow cytometry
Human cell samples were stained using fluorescein isothiocya-
nate (FITC) anti-CX3CR1 (MBL International, Woburn,
Massachusetts, USA), PE anti-CCR2, PE anti-DC-specific
intercellular adhesion molecule-3-grabbing non-integrin
(SIGN) (R&D Systems Inc., Minneapolis, Minnesota, USA),
PE anti-human leukocyte antigen (HLA)-DR, PE anti-CD62L, PE
anti-CD80, PE anti-CD86, PE anti-CD16 and APC anti-CD14
(BD Biosciences, San Jose, California, USA), PE anti-CD83 and
PE-DC-lysosome-associated membrane glycoprotein (LAMP)
(Immunotech, Marseille, France). Murine samples were stained
using biotinylated anti-CD11c, followed by allophycocyanin
(APC)–streptavidin (BD Biosciences).
Reverse transmigration assay
Development of DCs from monocytes was studied in a reverse
transmigration assay.17 Briefly, human umbilical vein endothe-
lial cells (HUVECs) were grown to confluency on a collagen
matrix (Allergan, Irvine, California, USA). PBMCs were
depleted of naturak killer (NK) cells using CD56-microbeads
(Miltenyi). CD16+ cells were then isolated using CD16-
microbeads and labelled with 5(6)-carboxyfluorescein diacetate
N-succinimidyl ester (Sigma Aldrich, Deisenhofen, Germany).
CD16+ and CD16– cells were remixed and applied to the
endothelial layer for 2 h. Afterwards, non-adherent cells were
washed away and culture was continued for 48 h. Reverse
transmigrated cells were then removed using 1 mM ethylene-
diaminetetraacetic acid (EDTA). All cultures used Ham F12
culture medium (BioWhittaker, Verviers, Belgium), supplemen-
ted with 20% fetal calf serum (FCS) (BioWhittaker), 50 mg/ml
endothelial cell growth supplement (R&D Systems) and 100 mg/
ml heparin (Sigma).
Cytokine measurements
Levels of interleukin (IL)10, IL1b, tumour necrosis factor
(TNF)a and IFNc were determined using a human cytokine
25-plex AB Bead kit (Biosource, Camarillo, California, USA).
Measurements were performed on a Luminex XYP (Luminex,
Austin, Texas, USA) and analysed using StarStation software
V.2.0 (Applied Cytometry Systems, Sheffield, UK).
Immunohistochemistry
Labial and parotid biopsies were snap-frozen in Tissue-Tek
(Sakura, Zoetermeer, The Netherlands). Cryostat sections
(6 mm) were prepared and fixed with cold methanol and
acetone. To limit background staining, an avidin/biotin block
was used (Vector Laboratories, Burlingame, California, USA).
Slides were incubated with anti-DC-LAMP (Immunotech,
Marseille, France), anti-DC-SIGN or IgG control (BD
Biosciences) followed by biotinylated rabbit anti-mouse IgG
and subsequent streptavidin-ABComplex-AP (Dako A/S,
Glostrup, Denmark). Alkaline phosphatase (AP) label was
developed using new fuchsine staining (Chroma, Stuttgart,
Germany). Slides were counterstained with haematoxylin
(Merck, Whitehouse Station, New Jersey, USA).
In vivo monocyte tracking
Monocyte subsets were labelled as described previously.26
Briefly, for labelling of Ly-6Clow monocytes, mice were injected
with Fluoresbrite plain YG 0.5 micron microspheres
(Polysciences Inc. Warrington, Pennsylvania, USA) intrave-
nously in the tail vein. Before labelling of Ly-6Chigh monocytes,
mice were injected with Cl2MDP (dichloromethyl diphospho-
nate; clodronate) liposomes intravenously in the tail vein.
Clodronate was a gift of Roche Diagnostics GmbH, Mannheim,
Germany. It was encapsulated in liposomes as described
previously.27 This results in a transient depletion of blood
monocytes, followed by repopulation of Ly-6Chigh monocytes.18
At 20 h later, these mice also received Fluoresbrite microspheres
intravenously, thus labelling the Ly-6Chigh population. At 4 days
later, submandibular glands (SMG) were removed and cleared of
all adipose tissue and lymph nodes. Tissue was then digested
using Liberase (Roche, Woerden, The Netherlands) treatment
and cells were washed twice in phosphate-buffered saline (PBS)
containing 10% FCS. Cell suspensions were then analysed by
flow cytometry.
Statistics
For comparison of unpaired data, the Mann–Whitney U test
was used. For comparison of paired data, the Wilcoxon signed
ranks test was used. Correlations were calculated using
Spearman rank test. All analyses were carried out using SPSS
software (SPSS, Chicago, Illinois, USA), results were considered
statistically significant if p,0.05.
RESULTS
Increase in mature monocytes in pSjS
PBMC were stained for CD14 and CD16 and frequencies of
mature and immature monocyte subsets were determined by
flow cytometry. The frequency of CD16+ mature monocytes
was significantly increased in pSjS compared to healthy controls
(fig 1A), while the frequency of CD16– immature monocytes
was not altered significantly (data not shown). Several
cytokines have been reported to induce the upregulation of
CD16 on monocytes in vitro, including IL10.28 Although levels
of IL10 were increased in the serum of patients with pSjS
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(fig 1B), no correlation was found between the level of IL10 and
the frequency of CD16+ monocytes (fig 1C, Spearman rho
20.385, p = 0.19). Additionally, levels of the inflammatory
cytokines IL1b, TNFa and IFNc did not correlate to CD16+
frequency (fig 1C, Spearman rho 0.067, 20.061 and 20.086,
p = 0.72, 0.74 and 0.65 respectively). Furthermore, no correla-
tion between frequency of mature monocytes and disease
duration was found (fig 1C, Spearman Rho 0.094, p = 0.76).
Normal phenotype of mature monocytes in pSjS
Besides expression of CD16, mature monocytes are charac-
terised as CCR2lowCD62LlowCX3CR1high. Expression of these
markers was determined, as an aberrant expression pattern
would have implications for the migration of this subset.
Mature monocytes expressed low levels of CCR2 and CD62L
and high levels of CX3CR1 (fig 2A). For comparison, immature
monocytes expressed low levels of CX3CR1 and high levels of
CCR2 and CD62L (fig 2B). No differences were observed
between pSjS and controls, indicating that the monocyte
subsets are phenotypically normal in pSjS with regard to these
migration markers and would be expected to show a normal
migration pattern.
Mature monocytes are capable of developing into DC-LAMP+
dendritic cells
The mature monocyte subset has been described to preferen-
tially develop into tissue trafficking DCs,17 but the exact
phenotype of these DCs is unknown. To determine the
phenotype of DCs derived from the mature monocyte subset,
the reverse transmigration model was used. In this system,
monocytes develop into DCs while traversing through endothe-
lial cells as well as the extracellular matrix, thus abolishing the
need for addition of exogenous cytokines.17 To specifically study
DCs originating from mature monocytes, this subset was
isolated from PBMCs obtained from controls, labelled with
carboxyfluorescein succinimidyl ester (CFSE) and remixed with
the original PBMCs. This total population was then used in the
reverse transmigration system. After 48 h, the reverse transmi-
gration fraction contained a clear population of DCs with cell
surface ruffling and dendrites (fig 3A). This population
contained CFSE+ and CFSE– cells, indicating that these cells
are of CD16+ mature and CD16– immature origin. DCs derived
from both monocyte subsets uniformly expressed HLA-DR at
Figure 1 Increased frequency of mature monocytes in primary Sjo¨gren
syndrome (pSjS) does not correlate to cytokine levels. A. Peripheral
blood mononuclear cells (PBMCs) were isolated, stained for CD14 and
CD16 and analysed by flow cytometry. Each data point represents one
individual patient, *p,0.05. B,C. Serum cytokine levels were measured
by 25-plex AB Bead kit. Disease duration was measured as time from
diagnosis to inclusion in the study. Each data point represents one
individual patient, dashed lines represent detection limits.
Figure 2 Normal chemokine receptor and adhesion molecule
expression on primary Sjo¨gren syndrome (pSjS) monocyte subsets.
Peripheral blood mononuclear cells (PBMCs) were separated into CD16+
and CD16– populations using magnetic bead isolation and stained for
CD14, chemokine (C–C motif) receptor 2 (CCR2), CD62L and CX3CR1.
CD14lowCD16+ (A) and CD14+CD16– (B) monocytes were gated and
analysed by flow cytometry. Expression was calculated as mean
fluorescence intensity (MFI) specific antibody–MFI isotype control,
n = 4–6.
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high levels (fig 3B). Previously, our group has reported the
increased presence of CD83+ and CD1a+ DC in the salivary
glands of patients with pSjS.6 CD83 was present on a
considerable proportion of DCs generated, especially in those
generated from mature monocytes (fig 3B). CD1a+ DC were
only rarely generated (2%), and originated solely from immature
monocytes (data not shown).
Recently, two more DC markers were described, DC-SIGN
and DC-LAMP.29 30 Expression of DC-SIGN was observed in up
to 70% of DCs derived from mature monocytes, but was more
common in DCs derived from the immature subset (up to 89%,
fig 3B). Contrary to this, expression of DC-LAMP was present
in significantly larger proportions of DCs derived from mature
monocytes (fig 3B). Similarly, expression of activation marker
CD80 also tended to be higher in CD14lowCD16+ derived DCs
(fig 3B).
DC-LAMP+ DCs are present in lymphocytic infiltrates in pSjS
salivary gland
Data on the expression of DC-SIGN and DC-LAMP in the
salivary glands of patients with pSjS has not been reported thus
far. Therefore, expression of these markers was studied in labial
or parotid biopsies obtained from four patients with pSjS.
Expression of DC-SIGN could readily be observed in all four
patients in the lymphocytic infiltrates and scattered throughout
the parenchyma (fig 4A). DC-LAMP+ cells were clearly present
as well, with an expression pattern restricted to the lympho-
cytic infiltrates (fig 4A).
Mouse homologue subset of mature monocytes migrates to
salivary gland and preferentially develops into DCs
To monitor monocyte trafficking in vivo, the NOD mouse model
was used. This strain spontaneously develops lymphocytic
infiltrates in the salivary glands similar to those seen in patients
with pSjS7 and exhibits an expansion of Ly6Clow mature
monocytes.23 Ly-6Clow mature and Ly-6Chigh immature monocytes
were labelled in vivo using latex beads labelled with the
fluorescent marker Yellow–Green (YG).26 SMG were removed
4 days later and analysed for presence of YG+ cells by flow
cytometry. Although SMG total cell suspensions show some
autofluorescence, a clear population of YG+ cells could be
observed in all mice (fig 5A), regardless of the monocyte subset
labelled. The YG+ population in the SMG was then further
analysed for expression of the dendritic cell marker CD11c. YG+
cells derived from mature monocytes cells were largely positive for
CD11c (mean 59 (14)%), indicating their dendritic nature (fig 5B).
In contrast, expression of CD11c on YG+ cells derived from
immature monocytes was significantly lower (mean 36 (8)%,
fig 5B,C). This supports the idea that although both populations
migrate to the SMG, mature monocytes preferentially develop
into tissue DCs.
DISCUSSION
This study shows that in pSjS the frequency of CD16+ mature
monocytes is increased compared to controls. Similar data has
been described for patients with RA,13 19 although in our results,
the increase in CD16+ monocytes in RA was less pronounced
than that in pSjS (data not shown). The mature subset
expresses normal levels of chemokine receptors and adhesion
molecules. DCs derived from mature monocytes partly express
DC-LAMP and CD83, a phenotype similar to DCs in pSjS
salivary gland.
Increased levels of CD16+ monocytes have been described in
systemic infection and sepsis, where cytokines were suggested
to be the causal factor.21 31 32 Since in our patient cohort no
correlation between CD16+ frequency and these cytokines
could be found, a straightforward cytokine effect appears to be
Figure 3 Mature monocyte derived
dendritic cells (DCs) partly express CD83
and DC-lysosome-associated membrane
glycoprotein (LAMP). CD16+ monocytes
were isolated from control peripheral
blood mononuclear cells (PBMCs) by
magnetic isolation and labelled using
carboxyfluorescein succinimidyl ester
(CFSE). Cells were then remixed and
applied to the reverse transmigration
system. A. After 48 h, reverse
transmigrated cells were harvested and
showed ruffled membranes. B. DCs were
harvested and CFSE+ and CFSE– DCs
were analysed separately for marker
expression by flow cytometry.
HLA-DR, human leukocyte antigen-DR;
SIGN, specific intercellular adhesion
molecule-3-grabbing non-integrin.
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unlikely. Additionally, levels of mature monocytes did not
correlate with disease duration, thus contradicting the idea that
the increased frequency of this subset is simply due to an
ongoing systemic inflammation.
The fate of mature monocytes after leaving the circulation
has been poorly elucidated. Most data on the developmental
fate of monocyte subsets has been derived from mouse studies
that focused on the homologue population of Ly-6Clow mature
monocytes.33 A recent report has shown that Ly-6Clow mono-
cytes can develop into lung DCs but not spleen DCs,34 thus
indicating that this subset may be mainly involved in the
seeding of DCs in non-lymphoid organs. In the NOD mouse, a
spontaneous model for pSjS,22 an increase in mature monocytes
and salivary gland infiltrating CD11c+ DCs was observed.7 23
This study shows that mature monocytes indeed have the
capacity to migrate into the submandibular glands, and develop
into CD11c+ cells more often then their immature counterparts.
In mice, expression of CD11c is mainly found on DCs and
alveolar macrophages, with only low levels being expressed by
other macrophage subsets.35 36 Given the high expression of
CD11c on Ly-6Clow monocyte derived cells in the NOD salivary
gland, these cells are most likely DCs. Recently, the NOD
mouse model was reported to lack longitudinal stability with
regard to the development of SjS-like symptoms.37 In the current
study, the decrease in salivary flow was not analysed, so a direct
link between monocyte infiltration and decreased salivary flow
could not be established. However, the results do show that Ly-
6Clow monocytes are capable of migrating to the salivary glands
and preferentially develop into DCs. Although the populations of
CD16+ and Ly-6Clow monocytes cannot be taken as completely
identical, this strongly supports the idea that mature monocytes
preferentially differentiate into tissue DCs.
The inhibitory FcGRIIb marker has been implicated in
maturation of DCs from monocytes in humans. Blocking this
receptor results in increased DC maturation and activation,
suggesting the FcGRIIb is a marker of relatively immature
monocytes.38 Indeed, expression of this receptor is decreased in
CD16+ monocytes compared to CD16– monocytes as deter-
mined at the mRNA level (data not shown), confirming the
hypothesis that CD16+ monocytes are more prone to develop
into DCs than their CD16– counterpart.
Previously our group has shown that increased numbers of
CD83+ and CD1a+ DCs are present in labial salivary glands of
patients with pSjS.6 In addition to this, it is shown here that the
recently described markers DC-SIGN and DC-LAMP29 30 are
expressed by DCs in pSjS labial and parotid salivary glands,
Figure 4 Dendritic cell (DC)-specific intercellular adhesion molecule-3-
grabbing non-integrin (SIGN) and DC-lysosome-associated membrane
glycoprotein (LAMP) have different expression patterns in primary
Sjo¨gren syndrome (pSjS) salivary gland. Frozen parotid (left) or labial
(right) biopsies of four pSjS patients were analysed by
immunohistochemistry, representative stainings are shown. A. DC-
SIGN+ cells are scattered throughout the parenchyma (magnification
3206). B. DC-LAMP+ cells are restricted to the focal infiltrates
(magnification 3206).
Figure 5 Mature mouse monocytes develop into salivary gland
CD11c+ dendritic cells (DCs). A. Ly-6Clow (left) and Ly-6Chigh (right)
monocytes were labelled using Yellow–Green (YG)-dyed beads and
presence of YG+ cells in the submandibular glands (SMG) was analysed
after 4 days. B. YG+ cells were gated and analysed for expression of
CD11c, a representative picture of each labelling is shown. C. YG+ cells
isolated from SMG were gated and analysed for expression of CD11c+,
boxplots represent median with upper and lower quartiles, whiskers
represent range (n = 7–10), *p,0.01.
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with expression of DC-LAMP restricted to the lymphocytic
infiltrates. The importance of DCs for the formation of
pathological infiltrates is shown by the fact that insulitis does
not develop in the absence of macrophages and DCs.
Furthermore, specific expansion of the DC population in a
mouse model results in the formation of lymphocytic infiltra-
tion of the salivary glands.39 40 To test if mature monocytes can
develop in vitro into DCs displaying the phenotype seen in
salivary glands, the reverse transmigration system was used.17
This system allows for monocytes to rapidly differentiate into
DCs without the need for addition of cytokines. The cells used
in this assay are obviously still capable of producing cytokines
themselves, and these may impact the process in a paracrine
fashion. Therefore, this system should not be considered as
‘‘cytokine-free’’, but rather as a closer resemblance of the
physiological environment than cultures in the presence of
excess amounts of exogenous cytokines. Both monocyte subsets
developed into DCs expressing high levels of HLA-DR, with a
large proportion of cells also expressing DC-SIGN. Expression of
CD83 and DC-LAMP was detected in particular on DCs derived
from mature monocytes. A similar trend was observed for
CD80, indicative of a more activated DC phenotype. This is in
line with previous observations, where increased expression of
CD86 was observed in CD16+ derived DC.41 Only low numbers
of CD1a+ DCs were detected, and originated solely from
immature monocytes. This indicates that the CD1a+ DCs
present in the SjS salivary gland may be a separate subset from
the DCs displaying the activated phenotype. These results
originate from in vitro experiments, which lack the local
influence of the salivary gland. Cytokines produced by the
glandular epithelium or infiltrating immune cells may also
impact the differentiation of DCs, leading to different expres-
sion patterns than those described here. Therefore, although
this data shows that mature monocytes have the capacity to
develop into activated DCs, whether they preferentially do so
specifically in salivary glands requires further confirmation in
vivo.
In summary, patients with pSjS show increased numbers of
mature CD16+ monocytes, which have the capacity to develop
into CD83+ and DC-LAMP+ DCs, similar to the type of DC
observed in salivary gland infiltrates in patients with pSjS.
Direct tracking of monocyte subsets is not possible in humans
due to ethical restraints, but our studies in the NOD mouse
support the model of the mature monocyte subset migrating to
the salivary glands and preferentially developing into DCs.
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